Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Essential Information for Investing in Ensign (ENSG)

Shares of Ensign have moved -8.2% today, and are now trading at a price of $156.42. In contrast, the S&P 500 index saw a 0.0% change. Today's trading volume is 2,279,880 compared to the stock's average volume of 441,420.

The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. Based in San Juan Capistrano, United States the company has 46,000 full time employees and a market cap of $9,142,029,312. Ensign currently offers its equity investors a dividend that yields 0.1% per year.

The company is now trading -29.03% away from its average analyst target price of $220.4 per share. The 5 analysts following the stock have set target prices ranging from $210.0 to $230.0, and on average give Ensign a rating of buy.

Over the last 52 weeks, ENSG stock has risen 9.9%, which amounts to a -17.3% difference compared to the S&P 500. The stock's 52 week high is $218.0 whereas its 52 week low is $134.79 per share. With its net margins declining an average -0.5% over the last 6 years, Ensign may not have a strong enough profitability trend to support its stock price.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2025 5,057,841 343,971 7 0.0
2024 4,260,485 297,973 7 16.67
2023 3,729,355 209,399 6 -14.29
2022 3,025,468 224,681 7 0.0
2021 2,627,461 194,652 7 0.0
2020 2,402,596 170,478 7
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS